Bridgewater, NJ, United States of America

Yingxin Shi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Insmed Incorporated. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yingxin Shi. Retrieved from https://idiyas.com/inventor/yingxin-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yingxin Shi: Inventor in Pharmaceutical Research.

Introduction

Yingxin Shi is an inventor associated with Bridgewater, New Jersey, and Insmed Incorporated. Her patent work concerns pharmaceutical compounds and potential treatments involving dipeptidyl peptidase 1 (DPP1) inhibitors.

Latest Patents

Shi is associated with 1 patent: “Linear Dipeptidyl Peptidase 1 Inhibitors and Uses Thereof.” The patent describes compounds of Formula (I), including pharmaceutically acceptable salts and deuterated forms, as well as pharmaceutical compositions containing them. It also outlines methods for using these compounds to treat diseases that may be addressed through DPP1 inhibition.

Career Highlights

Shi’s listed invention reflects research into medicinal compounds and their potential therapeutic applications. Her work is associated with Insmed Incorporated, a biopharmaceutical company.

Collaborations

The provided information lists Adam J. Plaunt and Byungchan Kim as Shi’s coworkers. Their names appear alongside her in connection with the company and patent information.

Conclusion

Yingxin Shi’s patent activity highlights her contribution to pharmaceutical innovation through research on DPP1 inhibitors and their potential uses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…